(Children's National Health System) While a PAPPA2 mutation is rare, endocrinologists, who understand its function and dysregulation can create solutions to support IGF-1 bioavailability, thereby supporting patterns of healthy growth and development in children. This research was presented at the European Society of Pediatric Endocrinology in Athens and will be discussed at endocrinology conferences in 2019.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2PEYGVn
No comments:
Post a Comment